risperidone has been researched along with sarcosine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chong, MY; Lane, HY; Lange, N; Tsai, G; Yang, P | 1 |
| Chang, YC; Chiu, CC; Lane, HY; Liu, YC; Tsai, GE | 1 |
| Hertel, P; Jardemark, KE; Konradsson, A; Marcus, MM; Svensson, TH | 1 |
| Barkoczy, J; Harsing, LG; Juranyi, Z; Levay, G; Marko, B; Matyus, P; Nagy, K; Pallagi, K; Szabo, G; Zsilla, G | 1 |
| Ahmad, MA; Akhtar, M; Kumar, V; Najmi, AK | 1 |
2 trial(s) available for risperidone and sarcosine
| Article | Year |
|---|---|
Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia.
Topics: Adult; Affective Symptoms; Amino Acid Transport Systems, Neutral; Analysis of Variance; Antipsychotic Agents; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Glycine Plasma Membrane Transport Proteins; Humans; Male; Receptors, N-Methyl-D-Aspartate; Risperidone; Sarcosine; Schizophrenia | 2004 |
Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study.
Topics: Acute Disease; Adult; Antipsychotic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Placebos; Psychiatric Status Rating Scales; Risperidone; Sarcosine; Schizophrenia; Schizophrenic Psychology; Serine; Stereoisomerism; Treatment Outcome | 2005 |
3 other study(ies) available for risperidone and sarcosine
| Article | Year |
|---|---|
Inhibition of the glycine transporter GlyT-1 potentiates the effect of risperidone, but not clozapine, on glutamatergic transmission in the rat medial prefrontal cortex.
Topics: Animals; Biological Transport, Active; Clozapine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Excitatory Postsynaptic Potentials; GABA Antagonists; Glutamic Acid; Glycine; Glycine Plasma Membrane Transport Proteins; Male; Organ Culture Techniques; Prefrontal Cortex; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Risperidone; Sarcosine; Synaptic Transmission | 2006 |
Alterations in brain extracellular dopamine and glycine levels following combined administration of the glycine transporter type-1 inhibitor Org-24461 and risperidone.
Topics: Animals; Corpus Striatum; Dopamine; Extracellular Space; Glycine; Glycine Plasma Membrane Transport Proteins; Male; Microdialysis; Protein Binding; Rats; Risperidone; Sarcosine | 2010 |
Effect of Sarcosine (a Glycine Transport 1 Inhibitor) and Risperidone (an Atypical antipsychotic Drug) on MK-801 Induced Learning and Memory Deficits in Rats.
Topics: Animals; Antipsychotic Agents; Dizocilpine Maleate; gamma-Aminobutyric Acid; Glycine; Glycine Plasma Membrane Transport Proteins; Learning Disabilities; Male; Memory Disorders; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Risperidone; Sarcosine; Serotonin | 2016 |